Alberto Zafra-Gómez

Dr. Alberto Zafra-Gómez

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Talanta
Verified
Journal Article
Closed access
LMLaura Martín-Pozo
Laura Martín-Pozo
BABlanca de Alarcón-Gómez
Blanca de Alarcón-Gómez
RRRocío Rodríguez-Gómez
Rocío Rodríguez-Gómez
MGMaría Teresa García-Córcoles
María Teresa García-Córcoles
MÇMorsina Çipa
Morsina Çipa
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez

1 December 2014 in Talanta
Verified
Journal Article
Closed access
FCF.J. Camino-Sánchez
F.J. Camino-Sánchez
RRR. Rodríguez-Gómez
R. Rodríguez-Gómez
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez
ASA. Santos-Fandila
A. Santos-Fandila
JVJ. L. Vilchez
J. L. Vilchez

6 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
NANatalia Andújar
Natalia Andújar
YOYolanda Gálvez Ontiveros
Yolanda Gálvez Ontiveros
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez
LRLourdes Rodrigo
Lourdes Rodrigo
María Jesús Alvarez CuberoMaría Jesús Alvarez Cubero
María Jesús Alvarez Cubero
Ana RivasAna Rivas
Ana Rivas
Bisphenol A (BPA) is the most well-known compound from the bisphenol family. As BPA has recently come under pressure, it is being replaced by compounds very similar in structure, but data on the occurrence of these BPA analogues in food and human matrices are limited. The main objective of this work was to investigate human exposure to BPA and analogues and the associated health effects. We performed a literature review of the available research made in humans, in in vivo and in vitro tests. The findings support the idea that exposure to BPA analogues may have an impact on human health, especially in terms of obesity and other adverse health effects in children.

1 May 2013 in Journal of Environmental Management
Verified
Journal Article
Closed access
NDN. Dorival-García
N. Dorival-García
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez
ANA. Navalón
A. Navalón
JGJ. González-López
J. González-López
EHE. Hontoria
E. Hontoria
JVJ. L. Vilchez
J. L. Vilchez

1 January 2013 in Science of The Total Environment
Verified
Journal Article
Closed access
NDN. Dorival-García
N. Dorival-García
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez
ANA. Navalón
A. Navalón
JGJ. González
J. González
JVJ. L. Vilchez
J. L. Vilchez

5 December 2022 in Science of The Total Environment
Verified
Journal Article
Open access
MGMaría del Carmen Gómez-Regalado
María del Carmen Gómez-Regalado
Julia MartinJulia Martin
Julia Martin
JSJuan Luis Santos
Juan Luis Santos
IAIrene Aparicio
Irene Aparicio
EAEsteban Alonso
Esteban Alonso
AZAlberto Zafra-Gómez
Alberto Zafra-Gómez
There is increasing evidence that the presence of certain pharmaceuticals in the environment leads to biota exposure and constitute a potential risk for ecosystems. Bioaccumulation is an essential focus of risk assessment to evaluate at what degree emerging contaminants are a hazard both to the environment and the individuals that inhabit it. The main goals of the present review are 1) to summarize and describe the research and factors that should be taken into account in the evaluation of bioaccumulation of pharmaceuticals in aquatic organisms; and 2) to provide a database and a critical review of the bioaccumulation/bioconcentration factors (BAF or BCF) of these compounds in organisms of different trophic levels. Most studies fall into one of two categories: laboratory-scale absorption and purification tests or field studies and, to a lesser extent, large-scale, semi-natural system tests. Although in the last 5 years there has been considerable progress in this field, especially in species of fish and molluscs, research is still limited on other aquatic species like crustaceans or algae. This revision includes >230 bioconcentration factors (BCF) and >530 bioaccumulation factors (BAF), determined for 113 pharmaceuticals. The most commonly studied is the antidepressant group, followed by diclofenac and carbamazepine. There is currently no reported accumulation data on certain compounds, such as anti-cancer drugs. BCFs are highly influenced by experimental factors (notably the exposure level, time or temperature). Field BAFs are superior to laboratory BCFs, highlighting the importance of field studies for reliable assessments and in true environmental conditions. BAF data appears to be organ, species and compound-specific. The potential impact on food web transfer is also considered. Among different aquatic species, lower trophic levels and benthic organisms exhibit relatively higher uptake of these compounds.